安泰康成

安泰康成

安泰康成

Biotech/Healthcare

Hunan Antai Kangcheng Biotechnology Co., Ltd. focuses on the R&D of innovative cancer treatment methods, medical devices and equipment, and technologies for central nervous system injury repair and rehabilitation, and is committed to commercializing advanced medical science and technology.

Latest round: Series A (2020)

Source: ChinaBulls — chinabulls.com

Last updated 2020-07-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.